
FDA Approves Triple Combination Drug GMRx2 (WIDAPLIK) for Hypertension Treatment
The US Food and Drug Administration (FDA) has approved GMRx2 (WIDAPLIK) for the treatment of hypertension in adult patients, as announced by London-based parent company George Medicines on June 9th, 2025. A US commercial launch is expected in the 4th …